A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborator:

Ortho-McNeil Janssen Scientific Affairs, LLC

Information provided by (Responsible Party):

Thomas J. Spencer, MD, Massachusetts General Hospital

ClinicalTrials.gov Identifier:

NCT00302458

First received: March 13, 2006

Last updated: November 1, 2012

Last verified: November 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2013
Primary Completion Date:	April 2008 (Final data collection date for primary outcome measure)

No publications provided by Massachusetts General Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Spencer TJ, Biederman J, Martin JM, Moorehead TM, Mirto T, Clarke A, Batchelder H, Faraone SV. Importance of pharmacokinetic profile and timing of coadministration of short- and long-acting formulations of methylphenidate on patterns of subjective responses and abuse potential. Postgrad Med. 2012 Jan;124(1):166-73.

To Top